(Q30399281)

21 June 2017

title

Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients (English)

1 reference

21 June 2017

0 references

Oriol Manuel

1

0 references

Thierry Calandra

object named as

Thierry Calandra

9

0 references

Matthias Cavassini

object named as

Matthias Cavassini

10

0 references

Stefano Giulieri

4

object named as

Stefano Giulieri

1 reference

21 June 2017

Manuel Pascual

2

1 reference

21 June 2017

Katja Hoschler

3

1 reference

21 June 2017

Deolinda Alves

5

1 reference

21 June 2017

Kim Ellefsen

6

1 reference

21 June 2017

Pierre-Alexandre Bart

7

1 reference

21 June 2017

Jean-Pierre Venetz

8

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

Clinical Infectious Diseases

21 June 2017

published in

1 reference

21 June 2017

volume

52

1 reference

21 June 2017

issue

2

1 reference

21 June 2017

page(s)

248-256

1 reference

Historical perspective--Emergence of influenza A (H1N1) viruses.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

H1N1 2009 influenza virus infection during pregnancy in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Guidance on novel influenza A/H1N1 in solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Response to a monovalent 2009 influenza A (H1N1) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

A novel influenza A (H1N1) vaccine in various age groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Effects of influenza immunization on humoral and cellular alloreactivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

Immunogenicity and Safety of an Intradermal Boosting Strategy for Vaccination Against Influenza in Lung Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ104

21 January 2018

Identifiers

DOI

10.1093/CID/CIQ104

1 reference

21 June 2017

1 reference